HTG2014-Section-Header-publications

2022

HTG Therapeutics White Paper HTP Proof of Concept

A Proof-of-concept Exploration of Transcriptome-informed
Drug Discovery Using the HTG Transcriptome Panel

Download pdf 562KB

2021

Comparison of Prototype HTG Transcriptome Panel

Comparison of Prototype HTG Transcriptome Panel to RNA-Seq

Download pdf 928KB

2020

Development and Verification of the HTG EdgeSeq Reveal Immune, Stroma and TME Signatures

Development and Verification of the HTG EdgeSeq™ Reveal Immune, Stroma and TME Signatures

Download pdf 870KB

Proof-of-Concept for a Whole Transcriptome Panel Using HTG EdgeSeq™ Technology

Proof-of-Concept for a Whole Transcriptome Panel Using HTG EdgeSeq™ Technology

Download pdf 192KB

2018

Detecting clinically relevant ALK rearrangements: Comparing the HTG EdgeSeq ALKPlus Assay EU (CE-IVD)to a commercially available ALK FISH assay

Numerous mutations have been shown to drive oncogenesis in non-small cell lung cancer (NSCLC). Measuring these events with conventional methods is difficult given the small amount of material typically collected in the standard needle core biopsy or similar tissue collection method.

Download pdf 735KB

2017

Page last updated May 22, 2023